CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS

Institutional investor · Portfolio as of Q1 2019

Top Holdings1,906 positions

Checking export access…
Activity:
SPYSPY
Unit

State Street Spdr S&p 500 Etf Trust TR UNIT

857,508$243.3M9.9%$223.02+13.53%
2 qtrssince 2018-Q4
Decreased
0
IVVIVV
ETF

iShares Trust CORE S&P500 ETF

417,820$118.9M4.8%$234.62+7.96%
2 qtrssince 2018-Q4
Increased
80
VUGVUG
ETF

Vanguard Index Funds MORNINGSTAR GROWTH ETF

450,419$70.6M2.9%$23.56+5.55%
2 qtrssince 2018-Q4
Increased
82
VTVVTV
ETF

VANGUARD INDEX FDS

554,516$60.1M2.4%$89.12+0.34%
2 qtrssince 2018-Q4
Increased
82
AGGAGG
ETF

ISHARES TR

504,790$55.1M2.2%$86.71+1.38%
2 qtrssince 2018-Q4
Increased
81
DONDON
ETF

WISDOMTREE U.S. MIDCAP DIVIDEND FUND

1.5M$54M2.2%$29.59+0.14%
2 qtrssince 2018-Q4
Increased
81

Apple Inc.

277,050$52.6M2.1%$38.27+18.17%
2 qtrssince 2018-Q4
Increased
57
EFAEFA
ETF

iShares Trust MSCI EAFE ETF

808,541$52.4M2.1%$47.49+10.53%
2 qtrssince 2018-Q4
Decreased
0
VIGVIG
ETF

VANGUARD DIVIDEND APPRECIATION ETF

475,064$52.3M2.1%$87.10+9.74%
2 qtrssince 2018-Q4
Increased
62
MDYMDY
ETF

State Street Spdr S&p Midcap 400 Etf Trust UTSER1 S&PDCRP

140,000$48.5M2.0%$275.46+14.41%
2 qtrssince 2018-Q4
Decreased
0
IJHIJH
ETF

ISHARES CORE S&P MID-CAP ETF

194,784$36.9M1.5%$31.33+8.21%
2 qtrssince 2018-Q4
Increased
67
VWOVWO
ETF

Vanguard International Equity Index Funds FTSE EMR MKT ETF

809,759$34.4M1.4%$30.85+10.76%
2 qtrssince 2018-Q4
Increased
49

Microsoft Corp.

290,342$34.2M1.4%$94.43+16.61%
2 qtrssince 2018-Q4
Decreased
0
VOOVOO
ETF

Vanguard Index Funds S&P 500 ETF SHS

124,106$32.2M1.3%$204.04+13.57%
2 qtrssince 2018-Q4
Decreased
0
VTIVTI
ETF

VANGUARD MORNINGSTAR TOTAL STOCK MARKET ETF

213,328$30.9M1.3%$117.36+10.42%
2 qtrssince 2018-Q4
Increased
57
SCHBSCHB
ETF

SCHWAB U.S. BROAD MARKET ETF

412,282$28.1M1.1%$9.63+5.53%
2 qtrssince 2018-Q4
Increased
73
VOVO
ETF

VANGUARD INDEX FDS

165,263$26.7M1.1%$30.78+16.73%
2 qtrssince 2018-Q4
Decreased
0
VEAVEA
ETF

VANGUARD FTSE DEVELOPED MARKETS ETF

641,583$26.3M1.1%$31.92+2.57%
2 qtrssince 2018-Q4
Increased
73
IJRIJR
ETF

ISHARES CORE S&P SMALL CAP ETF

329,225$25.4M1.0%$64.64+6.39%
2 qtrssince 2018-Q4
Increased
68
PFFPFF
Preferred

iShares Trust PFD AND INCM SEC

679,510$24.8M1.0%$22.19+7.37%
2 qtrssince 2018-Q4
Increased
48
$2.5B
AUM
1,906
Positions
Q1 2019
Filing
HI score · 4.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q1'19
New4%Increased77%Decreased18%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q20%1-4Q80%1-2Y0%2Y+0%

CAPTRUST FINANCIAL ADVISORS manages $2.5B across 1906 positions as of Q1 2019. Top holdings: SPY (9.9%), IVV (4.8%), VUG (2.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4.5/5.0.

Q1 2019 Summary

Active quarter - 381 new positions, 141 exits, 699 increased. Top move: VUG (INCREASED, conviction 82). Portfolio: $2.5B across 1906 positions.

Top holdings by portfolio weight

Total AUM$2B
SPY9.88%
IVV4.83%
VUG2.87%
VTV2.44%
AGG2.23%
DON2.19%
AAPL2.14%
EFA2.13%
VIG2.12%
MDY1.97%
Other1.50%

Portfolio allocation by GICS sector

Sectors11
Unknown63.50%
Technology7.01%
Healthcare6.29%
Financial Services5.84%
Consumer Defensive3.54%
Industrials3.46%
Communication Services3.17%
Consumer Cyclical2.68%
Energy2.39%
Utilities1.33%
Other0.78%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(4.5 / 5.0)
Holdings P&L55
Conviction41
Concentration40
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ABBVABBVABBVIE INC
Q4 2024 → Q2 2026+588,526 shares+$214.7M
7Q
BCIBCIABRDN ETFS
Q4 2024 → Q2 2026+36,265 shares+$861,597
7Q
ADPTADPTADAPTIVE BIOTECHNOLOGIES COR
Q4 2024 → Q2 2026+10,529 shares+$436,994
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used